Journal ArticleOPEN ACCESS

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

  • Eikelboom J
  • Wallentin L
  • Connolly S
  • et al.
Circulation (2011) 123(21) 2363-2372
DOI: 10.1161/circulationaha.110.004747
N/ACitations
Citations of this article
62Readers
Mendeley users who have this article in their library.

Abstract

Background—Dabigatran 150 and 110 mg twice a day and warfarin are effective for stroke prevention in atrial fibrillation. The purpose of this study was to compare their risks of bleeding in the Ran...

Cite

CITATION STYLE

APA

Eikelboom, J. W., Wallentin, L., Connolly, S. J., Ezekowitz, M., Healey, J. S., Oldgren, J., … Yusuf, S. (2011). Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation. Circulation, 123(21), 2363–2372. https://doi.org/10.1161/circulationaha.110.004747

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free